AIDS Researchers Give Upbeat Reports at National Conference

Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

AIDS Researchers Give Upbeat Reports at National Conference

United Press International (10/20/93) (Wasowicz, Lidia)

San Francisco--Leading AIDS researchers reported renewed enthusiasm, optimism, and hope, as well as promising new vaccine tests to combat the deadly virus. Scientists continue to press on with studies of long-term survivors, combination drug therapies, and inoculation trials, attendees at the Sixth National AIDS Update Conference were told. More positive attitudes have replaced the discouragement and pessimism that followed last year's international AIDS conference in Berlin, where scientists presented disappointing study results. The studies reported at this conference were much more encouraging. Work with a group of drugs called protease inhibitors, which block the growth of infectious viruses, have so far been promising. Also, researchers are close to developing tests that can quickly measure the effectiveness of a particular treatment in an individual. Such screens would be significant in ensuring that patients would be neither over or under-treated. Further encouraging research indicates that early intervention with low doses of AZT in patients with high T-cell counts effectively delays progression of the disease. In addition, one pharmaceutical company reports "remarkable results" in the development of an AIDS vaccine.

931022
AD931909

Copyright © 1993 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.